Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Study Details
Study Description
Brief Summary
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Molecular changes in patients' melanoma tissue [at 120 months]
Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions.
Secondary Outcome Measures
- Improve the time between ordering the test and results entry into medical records [120 months]
To enhance the speed and detail of molecular mutation profiling of melanoma
Eligibility Criteria
Criteria
Inclusion criteria
-
Pathologically-proven diagnosis of melanoma.
-
Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.
Exclusion criteria
-
Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
-
Any patient unable or unwilling to provide consent.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Vanderbitl-Ingram Cancer Center | Nashville | Tennessee | United States |
Sponsors and Collaborators
- Vanderbilt-Ingram Cancer Center
Investigators
- Principal Investigator: Douglas Johnson, M.D., Vanderbilt-Ingram Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- VICC MEL 09109